Merck KGaA Has Loss on Greek Bonds That Paid for Drugs, FTD Says

Sept. 25 (Bloomberg) -- Greek bonds that Merck KGaA received in lieu of payment for drugs delivered to local hospitals lost almost two-thirds of their value, Financial Times Deutschland reported, citing a Merck spokesman. *Merck received bonds worth 55.6 million euros ($72 million) *Bonds covered outstanding bills of 60 million euros incurred between 2007 and 2009 *Greece repaid 12.4 million euros worth of bonds *Merck sold the rest for 8.1 million euros *Bayer AG, Fresenius SE and Biotest AG also took losses on Greek bonds. Link to Company News: MRK GY <Equity> CN <GO>

To contact the reporter on this story: Eva von Schaper in Munich at evonschaper@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net